Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 161

1.

Amendment to clinical research projects. Genetic marking with retroviral vectors to study the feasibility of stem cell gene transfer and the biology of hematopoietic reconstitution after autologous transplantation in multiple myeloma, chronic myelogenous leukemia, or metastatic breast cancer.

Dunbar CE, Nienhuis AW, Stewart FM, Quesenberry P, O'Shaughnessy J, Cowan K, Cottler-Fox M, Leitman S, Goodman S, Sorrentino BP, et al.

Hum Gene Ther. 1993 Apr;4(2):205-22. No abstract available.

PMID:
8098622
[PubMed - indexed for MEDLINE]
2.

Pilot study of high dose ICE (ifosfamide, carboplatin, etoposide) chemotherapy and autologous bone marrow transplant (ABMT) with neoR-transduced bone marrow and peripheral blood stem cells in patients with metastatic breast cancer.

O'Shaughnessy JA, Cowan KH, Wilson W, Bryant G, Goldspiel B, Gress R, Nienhuis AW, Dunbar C, Sorrentino B, Stewart FM, et al.

Hum Gene Ther. 1993 Jun;4(3):331-54. No abstract available.

PMID:
8338880
[PubMed - indexed for MEDLINE]
3.

Retroviral mediated transfer of the human multidrug resistance gene (MDR-1) into hematopoietic stem cells during autologous transplantation after intensive chemotherapy for metastatic breast cancer.

O'Shaughnessy JA, Cowan KH, Nienhuis AW, McDonagh KT, Sorrentino BP, Dunbar CE, Chiang Y, Wilson W, Goldspiel B, Kohler D, et al.

Hum Gene Ther. 1994 Jul;5(7):891-911.

PMID:
7526902
[PubMed - indexed for MEDLINE]
4.

Hemopoietic recovery and infectious complications in breast cancer and multiple myeloma after autologous CD34+ cell-selected peripheral blood progenitor cell transplantation.

De Rosa L, Anghel G, Pandolfi A, Riccardi M, Amodeo R, Majolino I.

Int J Hematol. 2004 Jan;79(1):85-91.

PMID:
14979484
[PubMed - indexed for MEDLINE]
5.

High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia.

Carella AM, Chimirri F, Podestà M, Pitto A, Piaggio G, Dejana A, Lerma E, Pollicardo N, Vassallo F, Soracco M, Benvenuto F, Valbonesi M, Carlier P, Vimercati R, Prencipe E, Gatti AM, Ferrara RA, Incagliato M, Florio G, Frassoni F.

Bone Marrow Transplant. 1996 Feb;17(2):201-5.

PMID:
8640167
[PubMed - indexed for MEDLINE]
6.

Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients.

Cowan KH, Moscow JA, Huang H, Zujewski JA, O'Shaughnessy J, Sorrentino B, Hines K, Carter C, Schneider E, Cusack G, Noone M, Dunbar C, Steinberg S, Wilson W, Goldspiel B, Read EJ, Leitman SF, McDonagh K, Chow C, Abati A, Chiang Y, Chang YN, Gottesman MM, Pastan I, Nienhuis A.

Clin Cancer Res. 1999 Jul;5(7):1619-28.

PMID:
10430060
[PubMed - indexed for MEDLINE]
Free Article
7.

[Autologous hematopoietic stem cell transplantation in chronic myeloid leukemia].

Boqué C, Grañena A.

Sangre (Barc). 1998 Apr;43(2):155-63. Review. Spanish. No abstract available.

PMID:
9656777
[PubMed - indexed for MEDLINE]
8.

Autotransplantation for chronic myeloid leukemia: is it useful?

Olavarria E.

Haematologica. 2002 Jan;87(1):3-6. No abstract available.

PMID:
11801458
[PubMed - indexed for MEDLINE]
Free Article
9.

A phase I study of autologous bone marrow transplantation with stem cell gene marking in multiple myeloma.

Stewart AK, Dubé ID, Kamel-Reid S, Keating A.

Hum Gene Ther. 1995 Jan;6(1):107-19. No abstract available.

PMID:
7703282
[PubMed - indexed for MEDLINE]
10.

High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis.

Meyers PA, Krailo MD, Ladanyi M, Chan KW, Sailer SL, Dickman PS, Baker DL, Davis JH, Gerbing RB, Grovas A, Herzog CE, Lindsley KL, Liu-Mares W, Nachman JB, Sieger L, Wadman J, Gorlick RG.

J Clin Oncol. 2001 Jun 1;19(11):2812-20.

PMID:
11387352
[PubMed - indexed for MEDLINE]
11.

High-dose chemotherapy and autologous bone marrow or stem cell reconstitution for solid tumors.

McGuire WP.

Curr Probl Cancer. 1998 May-Jun;22(3):135-77. Review.

PMID:
9659570
[PubMed - indexed for MEDLINE]
12.

Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma.

Lemoli RM, Cavo M, Fortuna A.

J Hematother. 1996 Aug;5(4):339-49.

PMID:
8877709
[PubMed - indexed for MEDLINE]
13.

Transplantation in patients with multiple myeloma: a multicenter comparative analysis of peripheral blood stem cell and allogeneic transplant.

Varterasian M, Janakiraman N, Karanes C, Abella E, Uberti J, Dragovic J, Raman SB, al-Katib A, Du W, Silver SM, Adams PT, Sensenbrenner L, Ratanatharathorn V.

Am J Clin Oncol. 1997 Oct;20(5):462-6.

PMID:
9345328
[PubMed - indexed for MEDLINE]
14.

A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer.

Hu WW, Long GD, Stockerl-Goldstein KE, Johnston LJ, Chao NJ, Negrin RS, Blume KG.

Clin Cancer Res. 1999 Nov;5(11):3411-8.

PMID:
10589752
[PubMed - indexed for MEDLINE]
Free Article
15.

Early harvest and late transplantation as an effective therapeutic strategy in multiple myeloma.

Gertz MA, Lacy MQ, Inwards DJ, Chen MG, Pineda AA, Gastineau DA, Greipp PR, Lust JA, Tefferi A, Witzig TE, Kyle RA, Litzow MR.

Bone Marrow Transplant. 1999 Feb;23(3):221-6.

PMID:
10084252
[PubMed - indexed for MEDLINE]
Free Article
16.

Long-term follow-up of gene-marked CD34+ cells after autologous stem cell transplantation for multiple myeloma.

Alici E, Björkstrand B, Treschow A, Aints A, Smith CI, Gahrton G, Dilber MS.

Cancer Gene Ther. 2007 Mar;14(3):227-32. Epub 2006 Nov 3.

PMID:
17082794
[PubMed - indexed for MEDLINE]
17.

Pilot study of MDR1 gene transfer into hematopoietic stem cells and chemoprotection in metastatic breast cancer patients.

Takahashi S, Aiba K, Ito Y, Hatake K, Nakane M, Kobayashi T, Minowa S, Shibata H, Mitsuhashi J, Tsukahara S, Ishikawa E, Suzuki R, Tsuruo T, Sugimoto Y.

Cancer Sci. 2007 Oct;98(10):1609-16. Epub 2007 Aug 7.

PMID:
17683514
[PubMed - indexed for MEDLINE]
18.

[Dose-reduced conditioning before allogeneic stem cell transplantation: principles, clinical protocols and preliminary results].

Schmid C, Weisser M, Ledderose G, Stötzer O, Schleuning M, Kolb HJ.

Dtsch Med Wochenschr. 2002 Oct 18;127(42):2186-92. German.

PMID:
12397547
[PubMed - indexed for MEDLINE]
19.

High-dose chemotherapy and autologous bone marrow plus peripheral blood stem cell transplantation for patients with lymphoma or metastatic breast cancer: use of marker genes to investigate hematopoietic reconstitution in adults.

Douer D, Levine A, Anderson WF, Gordon M, Groshen S, Khan A, Mohrbacher A, Muggia F, Shibata D.

Hum Gene Ther. 1996 Mar 20;7(5):669-84. No abstract available.

PMID:
8845392
[PubMed - indexed for MEDLINE]
20.

High intensity regimens with autologous hematopoietic stem cell transplantation as treatment of multiple myeloma.

Awedan AA.

Ann Transplant. 2002;7(2):38-43. Review.

PMID:
12416471
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk